Hypersensitivity to the active substance or to any of the excipients listed in Description.
Concurrent administration with oral phosphate, active vitamin D analogues (see Interactions).
Fasting serum phosphate above the normal range for age due to the risk of hyperphosphatemia (see Precautions).
Patients with severe renal impairment or end stage renal disease.